|
|
|
|
|
|
| Global CRO develops innovative features and engaging new content to better connect with drug development communities |
Raleigh, N.C., May 29, 2014 - (ACN Newswire) - INC Research, a leading global Phase I to IV clinical research organization (CRO), today announced the launch of an all-new website (www.incresearch.com) to deliver an interactive digital experience for stakeholders across the clinical development process. Featuring a modern design, streamlined architecture and innovative features allowing users to navigate and filter content in a whole new way, the site provides pharmaceutical and biotech companies, clinical research sites and other key stakeholders improved access to information through a more interactive environment. A key feature of the new website is dedicated therapeutic environments mirroring the Company's therapeutic focus and alignment of its clinical teams to respond to customer needs in the fastest-growing areas of clinical development.
"We're excited to launch a website that is uniquely different from anything else we've seen in the industry," said Neil Ferguson, Executive Vice President, Global Business Development, INC Research. "With an interactive design and the functionality to filter and customize content in a simple and intuitive way, we will provide a more engaging experience that better connects users to the information and resources they need and brings our 'I am INC Research' brand to life."
In addition to offering dedicated content for a wide variety of therapeutic areas, the redesigned site features a user-friendly interface that makes it easier for visitors to navigate and access the information most relevant to them. The site also has been mobile-optimized so users can connect to information and updates from their tablets or smartphones anywhere, anytime.
To experience the new INC Research website, please visit www.incresearch.com.
About INC Research
INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services for the world's pharmaceutical, biotech and medical device industries. As a therapeutically focused CRO, with a Trusted Process(R) delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, investigative sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
Contact:
Lori Dorer, Media +1-513-345-1685
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: General Announcement
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
